← Back to Clinical Trials
Recruiting NCT04670640

NCT04670640 Mechanistic Interventions and Neuroscience of Dissociation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04670640
Status Recruiting
Phase
Sponsor Emory University
Condition Dissociation
Study Type INTERVENTIONAL
Enrollment 350 participants
Start Date 2021-09-18
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
VibrationBreath FocusNo Distractions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 350 participants in total. It began in 2021-09-18 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to test the neurophysiological mechanisms of an intervention to reduce symptoms of dissociation in traumatized people. The intervention will be tested in dissociative traumatized people at two sites: Emory University and University of Pittsburgh. The researchers are interested in whether neural networks associated with attentional control and interoceptive awareness can be enhanced in this population. The researchers propose to evaluate whether different body-focused and non-body focused interventions can change these mechanisms.

Eligibility Criteria

Inclusion Criteria: * experience of at least one Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Criterion A trauma (assessed using the Life Events Checklist) * a score of 7 or higher on the Multiscale Dissociation Inventory (MDI) depersonalization subscale * willingness to participate in the study Exclusion Criteria: * actively psychotic and cognitively compromised individuals (assessed using the Moderate-severe cognitive impairment screening tool (MoCA) will be excluded * moderate or more severe substance dependence (assessed with the MINI) * persons with imminent risk of physical violence to self or others

Contact & Investigator

Central Contact

Negar Fani, PhD

✉ nfani@emory.edu

📞 404-712-0354

Principal Investigator

Negar Fani, PhD

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT04670640 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Dissociation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04670640 currently recruiting?

Yes, NCT04670640 is actively recruiting participants. Contact the research team at nfani@emory.edu for enrollment information.

Where is the NCT04670640 trial being conducted?

This trial is being conducted at Atlanta, United States, Pittsburgh, United States.

Who is sponsoring the NCT04670640 clinical trial?

NCT04670640 is sponsored by Emory University. The principal investigator is Negar Fani, PhD at Emory University. The trial plans to enroll 350 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology